Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
American journal of cardiovascular drugs : drugs, devices and other interventions
| American journal of cardiovascular drugs : drugs, devices and other interventions |
| Pubbl/distr/stampa | [Mairangi Bay, Auckland, N.Z.], : Adis International |
| Descrizione fisica | 1 online resource (volumes) : illustrations |
| Disciplina | 615.71 |
| Soggetto topico |
Cardiovascular agents
Cardiovascular system - Diseases - Treatment Cardiovascular Agents - therapeutic use Cardiology - instrumentation Cardiovascular Diseases - therapy Heart Diseases - drug therapy Agents cardiovasculaires Appareil cardiovasculaire - Maladies - Traitement |
| Soggetto genere / forma |
Periodical
Periodicals. |
| ISSN | 1179-187X |
| Formato | Materiale a stampa  |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996218571003316 |
| [Mairangi Bay, Auckland, N.Z.], : Adis International | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
American journal of cardiovascular drugs : drugs, devices and other interventions
| American journal of cardiovascular drugs : drugs, devices and other interventions |
| Pubbl/distr/stampa | [Mairangi Bay, Auckland, N.Z.], : Adis International |
| Descrizione fisica | 1 online resource (volumes) : illustrations |
| Disciplina | 615.71 |
| Soggetto topico |
Cardiovascular agents
Cardiovascular system - Diseases - Treatment Cardiovascular Agents - therapeutic use Cardiology - instrumentation Cardiovascular Diseases - therapy Heart Diseases - drug therapy Agents cardiovasculaires Appareil cardiovasculaire - Maladies - Traitement |
| Soggetto genere / forma |
Periodical
Periodicals. |
| ISSN | 1179-187X |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910154543203321 |
| [Mairangi Bay, Auckland, N.Z.], : Adis International | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Beneficial effects of perhexiline in cardiovascular disease states [[electronic resource] /] / Yuliy Y. Chirkov, Aaron L. Sverdlov and John D. Horowitz
| Beneficial effects of perhexiline in cardiovascular disease states [[electronic resource] /] / Yuliy Y. Chirkov, Aaron L. Sverdlov and John D. Horowitz |
| Autore | Chirkov Yuliy Y |
| Pubbl/distr/stampa | New York, : Nova Biomedical/Nova Science Publishers, 2010 |
| Descrizione fisica | 1 online resource (53 p.) |
| Disciplina | 616.1/22061 |
| Altri autori (Persone) |
SverdlovAaron L
HorowitzJohn D |
| Collana | Cardiology research and clinical developments |
| Soggetto topico |
Perhexiline - Therapeutic use
Angina pectoris - Chemotherapy Cardiovascular agents |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-61728-630-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Clinical applications of perhexiline -- Pharmacokinetics and toxicity of perhexiline -- Pharmacology of perhexiline -- Conclusion and future perspectives. |
| Record Nr. | UNINA-9910465957903321 |
Chirkov Yuliy Y
|
||
| New York, : Nova Biomedical/Nova Science Publishers, 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Beneficial effects of perhexiline in cardiovascular disease states [[electronic resource] /] / Yuliy Y. Chirkov, Aaron L. Sverdlov and John D. Horowitz
| Beneficial effects of perhexiline in cardiovascular disease states [[electronic resource] /] / Yuliy Y. Chirkov, Aaron L. Sverdlov and John D. Horowitz |
| Autore | Chirkov Yuliy Y |
| Pubbl/distr/stampa | New York, : Nova Biomedical/Nova Science Publishers, 2010 |
| Descrizione fisica | 1 online resource (53 p.) |
| Disciplina | 616.1/22061 |
| Altri autori (Persone) |
SverdlovAaron L
HorowitzJohn D |
| Collana | Cardiology research and clinical developments |
| Soggetto topico |
Perhexiline - Therapeutic use
Angina pectoris - Chemotherapy Cardiovascular agents |
| ISBN | 1-61728-630-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Clinical applications of perhexiline -- Pharmacokinetics and toxicity of perhexiline -- Pharmacology of perhexiline -- Conclusion and future perspectives. |
| Record Nr. | UNINA-9910791767703321 |
|
Chirkov Yuliy Y
|
||
| New York, : Nova Biomedical/Nova Science Publishers, 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Beneficial effects of perhexiline in cardiovascular disease states [[electronic resource] /] / Yuliy Y. Chirkov, Aaron L. Sverdlov and John D. Horowitz
| Beneficial effects of perhexiline in cardiovascular disease states [[electronic resource] /] / Yuliy Y. Chirkov, Aaron L. Sverdlov and John D. Horowitz |
| Autore | Chirkov Yuliy Y |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | New York, : Nova Biomedical/Nova Science Publishers, 2010 |
| Descrizione fisica | 1 online resource (53 p.) |
| Disciplina | 616.1/22061 |
| Altri autori (Persone) |
SverdlovAaron L
HorowitzJohn D |
| Collana | Cardiology research and clinical developments |
| Soggetto topico |
Perhexiline - Therapeutic use
Angina pectoris - Chemotherapy Cardiovascular agents |
| ISBN | 1-61728-630-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Clinical applications of perhexiline -- Pharmacokinetics and toxicity of perhexiline -- Pharmacology of perhexiline -- Conclusion and future perspectives. |
| Record Nr. | UNINA-9910810119503321 |
|
Chirkov Yuliy Y
|
||
| New York, : Nova Biomedical/Nova Science Publishers, 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiac drug safety [[electronic resource] ] : a bench to bedside approach / / Matthew J. Killeen
| Cardiac drug safety [[electronic resource] ] : a bench to bedside approach / / Matthew J. Killeen |
| Autore | Killeen Matthew J |
| Pubbl/distr/stampa | Singapore, : World Scientific Pub. Co., 2012 |
| Descrizione fisica | 1 online resource (189 p.) |
| Disciplina |
363.738/74
363.73874 615.71 |
| Soggetto topico | Cardiovascular agents |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-66922-5
9786613646156 981-4317-46-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Foreword; "Et causae quoque aestimatio saepe morbum solvit"* [Celsus: Prooemium 69, De Medicina]; Preface; Chapter 1 Challenges Facing the Pharmaceutical Industry in the 21st Century; Introduction; The Impact of Cardiac Toxicity on the Pharmaceutical Industry; References; Chapter 2 The Cellular Basis of Cardiac Electrophysiology; Introduction; The Initiation of the Heart Beat; The Ventricular Cardiac Action Potential; The Relationship Between the Cardiac Action Potential and the Electrocardiogram; Ion Channels Underlying the Cardiac Action Potential; Sodium channels
Calcium channels Potassium channels; Cardiac potassium channels; The transient outward potassium channel; Delayed rectifier potassium channels; The ultra rapid delayed rectifier potassium channel; The HERG potassium channel; The slowly activating delayed rectifier potassium channel; Inwardly rectifying potassium channels; Species-dependent variability of potassium channels; Potassium channel subunits; Summary; References; Chapter 3 Clinical Arrhythmia Syndromes; Introduction; The Long QT Syndrome; Congenital Long QT Syndrome; Drug-Induced QT Prolongation; Summary; References Chapter 4 The Mechanisms Underlying Cardiac Arrhythmias Introduction; Mechanisms Underlying Cardiac Arrhythmias; Abnormal Automaticity; Early and Delayed After depolarizations; Re-entry; Transmural Dispersion of Repolarization; How does Action Potential and QT Prolongation Generate Arrhythmias?; Does the M-Cell Play a Role in Arrhythmia Induction in Humans?; Using Mouse Models to Study Arrhythmia Mechanisms; Experimental Studies Exploring the Relationship Between Changes in Transmural Repolarization Gradients and Arrhythmias in Mouse Hearts Arrhythmia Mechanisms and Novel Antiarrhythmic Approaches Identified Using the Hypokalemic Mouse Model Summary; References; Chapter 5 The Mechanisms Underlying Drug-Induced Arrhythmias; Introduction; The Classical Model of Drug-Induced QT Prolongation and Proarrhythmia: HERG Blockade; Additional Mechanisms Contributing to Drug-Induced Arrhythmias; Drug-Induction Activation of Depolarizing Ion Channels; Drug-Induced Changes in Ion Channel Expression; Drug-Induced Sodium Channel Dysfunction; Summary; References; Chapter 6 Assessing Cardiac Safety in Drug Development; Introduction Preclinical Evaluation of Cardiac Drug Safety The ICH S7B Guidelines; Single Cell Safety Studies; The Purkinje Fiber Model; The Ventricular Wedge Model; Isolated Heart Models; In Vivo Models; The Impact of Species-Related Differences in Cardiac Electrophysiology on Preclinical Drug Safety Assessment; Methods to Provoke Arrhythmias in Preclinical Studies; Programmed electrical stimulation; Reductions in the extracellular K+ concentration; Clinical Evaluation of Cardiac Safety; The Thorough QT study; Thorough QT study design; Additional Biomarkers to Detect Drug-Induced Proarrhythmia Variability of repolarization |
| Record Nr. | UNINA-9910451573503321 |
|
Killeen Matthew J
|
||
| Singapore, : World Scientific Pub. Co., 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiac drug safety [[electronic resource] ] : a bench to bedside approach / / Matthew J. Killeen
| Cardiac drug safety [[electronic resource] ] : a bench to bedside approach / / Matthew J. Killeen |
| Autore | Killeen Matthew J |
| Pubbl/distr/stampa | Singapore, : World Scientific Pub. Co., 2012 |
| Descrizione fisica | 1 online resource (189 p.) |
| Disciplina |
363.738/74
363.73874 615.71 |
| Soggetto topico | Cardiovascular agents |
| ISBN |
1-280-66922-5
9786613646156 981-4317-46-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Foreword; "Et causae quoque aestimatio saepe morbum solvit"* [Celsus: Prooemium 69, De Medicina]; Preface; Chapter 1 Challenges Facing the Pharmaceutical Industry in the 21st Century; Introduction; The Impact of Cardiac Toxicity on the Pharmaceutical Industry; References; Chapter 2 The Cellular Basis of Cardiac Electrophysiology; Introduction; The Initiation of the Heart Beat; The Ventricular Cardiac Action Potential; The Relationship Between the Cardiac Action Potential and the Electrocardiogram; Ion Channels Underlying the Cardiac Action Potential; Sodium channels
Calcium channels Potassium channels; Cardiac potassium channels; The transient outward potassium channel; Delayed rectifier potassium channels; The ultra rapid delayed rectifier potassium channel; The HERG potassium channel; The slowly activating delayed rectifier potassium channel; Inwardly rectifying potassium channels; Species-dependent variability of potassium channels; Potassium channel subunits; Summary; References; Chapter 3 Clinical Arrhythmia Syndromes; Introduction; The Long QT Syndrome; Congenital Long QT Syndrome; Drug-Induced QT Prolongation; Summary; References Chapter 4 The Mechanisms Underlying Cardiac Arrhythmias Introduction; Mechanisms Underlying Cardiac Arrhythmias; Abnormal Automaticity; Early and Delayed After depolarizations; Re-entry; Transmural Dispersion of Repolarization; How does Action Potential and QT Prolongation Generate Arrhythmias?; Does the M-Cell Play a Role in Arrhythmia Induction in Humans?; Using Mouse Models to Study Arrhythmia Mechanisms; Experimental Studies Exploring the Relationship Between Changes in Transmural Repolarization Gradients and Arrhythmias in Mouse Hearts Arrhythmia Mechanisms and Novel Antiarrhythmic Approaches Identified Using the Hypokalemic Mouse Model Summary; References; Chapter 5 The Mechanisms Underlying Drug-Induced Arrhythmias; Introduction; The Classical Model of Drug-Induced QT Prolongation and Proarrhythmia: HERG Blockade; Additional Mechanisms Contributing to Drug-Induced Arrhythmias; Drug-Induction Activation of Depolarizing Ion Channels; Drug-Induced Changes in Ion Channel Expression; Drug-Induced Sodium Channel Dysfunction; Summary; References; Chapter 6 Assessing Cardiac Safety in Drug Development; Introduction Preclinical Evaluation of Cardiac Drug Safety The ICH S7B Guidelines; Single Cell Safety Studies; The Purkinje Fiber Model; The Ventricular Wedge Model; Isolated Heart Models; In Vivo Models; The Impact of Species-Related Differences in Cardiac Electrophysiology on Preclinical Drug Safety Assessment; Methods to Provoke Arrhythmias in Preclinical Studies; Programmed electrical stimulation; Reductions in the extracellular K+ concentration; Clinical Evaluation of Cardiac Safety; The Thorough QT study; Thorough QT study design; Additional Biomarkers to Detect Drug-Induced Proarrhythmia Variability of repolarization |
| Record Nr. | UNINA-9910779277703321 |
|
Killeen Matthew J
|
||
| Singapore, : World Scientific Pub. Co., 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiac drug safety : a bench to bedside approach / / Matthew J. Killeen
| Cardiac drug safety : a bench to bedside approach / / Matthew J. Killeen |
| Autore | Killeen Matthew J |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Singapore, : World Scientific Pub. Co., 2012 |
| Descrizione fisica | 1 online resource (189 p.) |
| Disciplina |
363.738/74
363.73874 615.71 |
| Soggetto topico | Cardiovascular agents |
| ISBN |
1-280-66922-5
9786613646156 981-4317-46-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Foreword; "Et causae quoque aestimatio saepe morbum solvit"* [Celsus: Prooemium 69, De Medicina]; Preface; Chapter 1 Challenges Facing the Pharmaceutical Industry in the 21st Century; Introduction; The Impact of Cardiac Toxicity on the Pharmaceutical Industry; References; Chapter 2 The Cellular Basis of Cardiac Electrophysiology; Introduction; The Initiation of the Heart Beat; The Ventricular Cardiac Action Potential; The Relationship Between the Cardiac Action Potential and the Electrocardiogram; Ion Channels Underlying the Cardiac Action Potential; Sodium channels
Calcium channels Potassium channels; Cardiac potassium channels; The transient outward potassium channel; Delayed rectifier potassium channels; The ultra rapid delayed rectifier potassium channel; The HERG potassium channel; The slowly activating delayed rectifier potassium channel; Inwardly rectifying potassium channels; Species-dependent variability of potassium channels; Potassium channel subunits; Summary; References; Chapter 3 Clinical Arrhythmia Syndromes; Introduction; The Long QT Syndrome; Congenital Long QT Syndrome; Drug-Induced QT Prolongation; Summary; References Chapter 4 The Mechanisms Underlying Cardiac Arrhythmias Introduction; Mechanisms Underlying Cardiac Arrhythmias; Abnormal Automaticity; Early and Delayed After depolarizations; Re-entry; Transmural Dispersion of Repolarization; How does Action Potential and QT Prolongation Generate Arrhythmias?; Does the M-Cell Play a Role in Arrhythmia Induction in Humans?; Using Mouse Models to Study Arrhythmia Mechanisms; Experimental Studies Exploring the Relationship Between Changes in Transmural Repolarization Gradients and Arrhythmias in Mouse Hearts Arrhythmia Mechanisms and Novel Antiarrhythmic Approaches Identified Using the Hypokalemic Mouse Model Summary; References; Chapter 5 The Mechanisms Underlying Drug-Induced Arrhythmias; Introduction; The Classical Model of Drug-Induced QT Prolongation and Proarrhythmia: HERG Blockade; Additional Mechanisms Contributing to Drug-Induced Arrhythmias; Drug-Induction Activation of Depolarizing Ion Channels; Drug-Induced Changes in Ion Channel Expression; Drug-Induced Sodium Channel Dysfunction; Summary; References; Chapter 6 Assessing Cardiac Safety in Drug Development; Introduction Preclinical Evaluation of Cardiac Drug Safety The ICH S7B Guidelines; Single Cell Safety Studies; The Purkinje Fiber Model; The Ventricular Wedge Model; Isolated Heart Models; In Vivo Models; The Impact of Species-Related Differences in Cardiac Electrophysiology on Preclinical Drug Safety Assessment; Methods to Provoke Arrhythmias in Preclinical Studies; Programmed electrical stimulation; Reductions in the extracellular K+ concentration; Clinical Evaluation of Cardiac Safety; The Thorough QT study; Thorough QT study design; Additional Biomarkers to Detect Drug-Induced Proarrhythmia Variability of repolarization |
| Record Nr. | UNINA-9910824978503321 |
|
Killeen Matthew J
|
||
| Singapore, : World Scientific Pub. Co., 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiotoxicity / / edited by Wenyong Tan
| Cardiotoxicity / / edited by Wenyong Tan |
| Pubbl/distr/stampa | [Place of publication not identified] : , : IntechOpen, , 2018 |
| Descrizione fisica | 1 online resource (112 pages) |
| Disciplina | 615.71 |
| Soggetto topico | Cardiovascular agents |
| ISBN |
1-83881-822-7
1-78984-238-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910317777803321 |
| [Place of publication not identified] : , : IntechOpen, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiovascular drug reviews
| Cardiovascular drug reviews |
| Pubbl/distr/stampa | [Branford, Conn.], : Neva Press |
| Descrizione fisica | 1 online resource |
| Disciplina | 616 |
| Soggetto topico |
Cardiovascular agents
Cardiovascular system - Diseases - Chemotherapy Cardiovascular Agents Cardiovascular Diseases - drug therapy Medicaments cardiovasculars Sistema cardiovascular Terapèutica |
| Soggetto genere / forma |
Periodical
Revistes electròniques |
| ISSN | 1527-3466 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996207843303316 |
| [Branford, Conn.], : Neva Press | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
